The economic benefits of reducing cardiovascular disease mortality in Quebec, Canada

We assess how different scenarios of cardiovascular disease (CVD) prevention, aimed at meeting targets set by the World Health Organization (WHO) for 2025), may impact healthcare spending in Quebec, Canada over the 2050 horizon. We provide long-term forecasts of healthcare use and costs at the Quebe...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2018-01, Vol.13 (1), p.e0190538-e0190538
Main Authors: Boisclair, David, Décarie, Yann, Laliberté-Auger, François, Michaud, Pierre-Carl, Vincent, Carole
Format: Article
Language:English
Subjects:
21st century
Aging
Analysis
Biology and Life Sciences
Cardiovascular disease
Cardiovascular diseases
Computer simulation
Control
Demographics
Diabetes
Disease prevention
Economic aspects
Health care
Health care costs
Heart attacks
Hospitals
Life expectancy
Life span
Medicine and Health Sciences
Mortality
Patient outcomes
People and places
Population
Risk analysis
Risk factors
Social Sciences
Stroke
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c692t-87798a38d68e53dc19c63cdd2f7bf38202e5281696cdf5f43801268048a213c83
cites cdi_FETCH-LOGICAL-c692t-87798a38d68e53dc19c63cdd2f7bf38202e5281696cdf5f43801268048a213c83
container_end_page e0190538
container_issue 1
container_start_page e0190538
container_title PloS one
container_volume 13
creator Boisclair, David
Décarie, Yann
Laliberté-Auger, François
Michaud, Pierre-Carl
Vincent, Carole
description We assess how different scenarios of cardiovascular disease (CVD) prevention, aimed at meeting targets set by the World Health Organization (WHO) for 2025), may impact healthcare spending in Quebec, Canada over the 2050 horizon. We provide long-term forecasts of healthcare use and costs at the Quebec population level using a novel dynamic microsimulation model. Using both survey and administrative data, we simulate the evolution of the Quebec population's health status until death, through a series of dynamic transitions that accounts for social and demographic characteristics associated with CVD risk factors. A 25% reduction in CVD mortality between 2012 and 2025 achieved through decreased incidence could contain the pace of healthcare cost growth towards 2050 by nearly 7 percentage points for consultations with a physician, and by almost 9 percentage points for hospitalizations. Over the 2012-2050 period, the present value of cost savings is projected to amount to C$13.1 billion in 2012 dollars. The years of life saved due to improved life expectancy could be worth another C$38.2 billion. Addressing CVD mortality directly instead would bring about higher healthcare costs, but would generate more value in terms of years of life saved, at C$69.6 billion. Potential savings associated with plausible reductions in CVD, aimed at reaching a World Health Organization target over a 12-year period, are sizeable and may help address challenges associated with an aging population.
doi_str_mv 10.1371/journal.pone.0190538
format article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1985141652</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A521670748</galeid><doaj_id>oai_doaj_org_article_ac9be6e38cc04572ac48a6ea8a10ea41</doaj_id><sourcerecordid>A521670748</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-87798a38d68e53dc19c63cdd2f7bf38202e5281696cdf5f43801268048a213c83</originalsourceid><addsrcrecordid>eNqNkl2LEzEUhgdR3HX1H4gOCKJgaz4mmcyNsBQ_CguLWr0Np8mZNmU66SYzi_vvzWxnl1b2QnKRcPKc9yTvOVn2kpIp5SX9uPF9aKGZ7nyLU0IrIrh6lJ3SirOJZIQ_PjifZM9i3JABkfJpdsIqTkip-Gm2WKwxR-Nbv3UmX2KLteti7us8oO2Na1e5gWCdv4Zo-gZCbl1EiJhvfeigcd1N7tr8e49LNB_yGbRg4Xn2pIYm4otxP8t-ffm8mH2bXFx-nc_OLyZGVqybqLKsFHBlpULBraGVkdxYy-pyWXPFCEPBFJWVNLYWdcEVoUwqUihglBvFz7LXe91d46MeDYmaVkrQgkrBEjHfE9bDRu-C20K40R6cvg34sNIQOmca1GCqJUrkyhhSiJKBSXUkggJKEAqatD6N1frlFq3BtgvQHIke37RurVf-WotSFERUSeDdKBD8VY-x01sXDTYNtOj723dXopDJlYS--Qd9-HcjtYL0AdfWPtU1g6g-F4zKkpTF4NL0ASoti6nnfuh4ih8lvD9KSEyHf7oV9DHq-c8f_89e_j5m3x6wa4SmW0ff9J3zbTwGiz1ogo8xYH1vMiV6GP47N_Qw_Hoc_pT26rBB90l3087_Asop_go</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1985141652</pqid></control><display><type>article</type><title>The economic benefits of reducing cardiovascular disease mortality in Quebec, Canada</title><source>Open Access: PubMed Central</source><source>Publicly Available Content (ProQuest)</source><creator>Boisclair, David ; Décarie, Yann ; Laliberté-Auger, François ; Michaud, Pierre-Carl ; Vincent, Carole</creator><creatorcontrib>Boisclair, David ; Décarie, Yann ; Laliberté-Auger, François ; Michaud, Pierre-Carl ; Vincent, Carole</creatorcontrib><description>We assess how different scenarios of cardiovascular disease (CVD) prevention, aimed at meeting targets set by the World Health Organization (WHO) for 2025), may impact healthcare spending in Quebec, Canada over the 2050 horizon. We provide long-term forecasts of healthcare use and costs at the Quebec population level using a novel dynamic microsimulation model. Using both survey and administrative data, we simulate the evolution of the Quebec population's health status until death, through a series of dynamic transitions that accounts for social and demographic characteristics associated with CVD risk factors. A 25% reduction in CVD mortality between 2012 and 2025 achieved through decreased incidence could contain the pace of healthcare cost growth towards 2050 by nearly 7 percentage points for consultations with a physician, and by almost 9 percentage points for hospitalizations. Over the 2012-2050 period, the present value of cost savings is projected to amount to C$13.1 billion in 2012 dollars. The years of life saved due to improved life expectancy could be worth another C$38.2 billion. Addressing CVD mortality directly instead would bring about higher healthcare costs, but would generate more value in terms of years of life saved, at C$69.6 billion. Potential savings associated with plausible reductions in CVD, aimed at reaching a World Health Organization target over a 12-year period, are sizeable and may help address challenges associated with an aging population.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0190538</identifier><identifier>PMID: 29300783</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>21st century ; Aging ; Analysis ; Biology and Life Sciences ; Cardiovascular disease ; Cardiovascular diseases ; Computer simulation ; Control ; Demographics ; Diabetes ; Disease prevention ; Economic aspects ; Health care ; Health care costs ; Heart attacks ; Hospitals ; Life expectancy ; Life span ; Medicine and Health Sciences ; Mortality ; Patient outcomes ; People and places ; Population ; Risk analysis ; Risk factors ; Social Sciences ; Stroke</subject><ispartof>PloS one, 2018-01, Vol.13 (1), p.e0190538-e0190538</ispartof><rights>COPYRIGHT 2018 Public Library of Science</rights><rights>2018 Boisclair et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2018 Boisclair et al 2018 Boisclair et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-87798a38d68e53dc19c63cdd2f7bf38202e5281696cdf5f43801268048a213c83</citedby><cites>FETCH-LOGICAL-c692t-87798a38d68e53dc19c63cdd2f7bf38202e5281696cdf5f43801268048a213c83</cites><orcidid>0000-0003-3114-4229</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1985141652/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1985141652?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25731,27901,27902,36989,36990,44566,53766,53768,74869</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29300783$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Boisclair, David</creatorcontrib><creatorcontrib>Décarie, Yann</creatorcontrib><creatorcontrib>Laliberté-Auger, François</creatorcontrib><creatorcontrib>Michaud, Pierre-Carl</creatorcontrib><creatorcontrib>Vincent, Carole</creatorcontrib><title>The economic benefits of reducing cardiovascular disease mortality in Quebec, Canada</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>We assess how different scenarios of cardiovascular disease (CVD) prevention, aimed at meeting targets set by the World Health Organization (WHO) for 2025), may impact healthcare spending in Quebec, Canada over the 2050 horizon. We provide long-term forecasts of healthcare use and costs at the Quebec population level using a novel dynamic microsimulation model. Using both survey and administrative data, we simulate the evolution of the Quebec population's health status until death, through a series of dynamic transitions that accounts for social and demographic characteristics associated with CVD risk factors. A 25% reduction in CVD mortality between 2012 and 2025 achieved through decreased incidence could contain the pace of healthcare cost growth towards 2050 by nearly 7 percentage points for consultations with a physician, and by almost 9 percentage points for hospitalizations. Over the 2012-2050 period, the present value of cost savings is projected to amount to C$13.1 billion in 2012 dollars. The years of life saved due to improved life expectancy could be worth another C$38.2 billion. Addressing CVD mortality directly instead would bring about higher healthcare costs, but would generate more value in terms of years of life saved, at C$69.6 billion. Potential savings associated with plausible reductions in CVD, aimed at reaching a World Health Organization target over a 12-year period, are sizeable and may help address challenges associated with an aging population.</description><subject>21st century</subject><subject>Aging</subject><subject>Analysis</subject><subject>Biology and Life Sciences</subject><subject>Cardiovascular disease</subject><subject>Cardiovascular diseases</subject><subject>Computer simulation</subject><subject>Control</subject><subject>Demographics</subject><subject>Diabetes</subject><subject>Disease prevention</subject><subject>Economic aspects</subject><subject>Health care</subject><subject>Health care costs</subject><subject>Heart attacks</subject><subject>Hospitals</subject><subject>Life expectancy</subject><subject>Life span</subject><subject>Medicine and Health Sciences</subject><subject>Mortality</subject><subject>Patient outcomes</subject><subject>People and places</subject><subject>Population</subject><subject>Risk analysis</subject><subject>Risk factors</subject><subject>Social Sciences</subject><subject>Stroke</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNkl2LEzEUhgdR3HX1H4gOCKJgaz4mmcyNsBQ_CguLWr0Np8mZNmU66SYzi_vvzWxnl1b2QnKRcPKc9yTvOVn2kpIp5SX9uPF9aKGZ7nyLU0IrIrh6lJ3SirOJZIQ_PjifZM9i3JABkfJpdsIqTkip-Gm2WKwxR-Nbv3UmX2KLteti7us8oO2Na1e5gWCdv4Zo-gZCbl1EiJhvfeigcd1N7tr8e49LNB_yGbRg4Xn2pIYm4otxP8t-ffm8mH2bXFx-nc_OLyZGVqybqLKsFHBlpULBraGVkdxYy-pyWXPFCEPBFJWVNLYWdcEVoUwqUihglBvFz7LXe91d46MeDYmaVkrQgkrBEjHfE9bDRu-C20K40R6cvg34sNIQOmca1GCqJUrkyhhSiJKBSXUkggJKEAqatD6N1frlFq3BtgvQHIke37RurVf-WotSFERUSeDdKBD8VY-x01sXDTYNtOj723dXopDJlYS--Qd9-HcjtYL0AdfWPtU1g6g-F4zKkpTF4NL0ASoti6nnfuh4ih8lvD9KSEyHf7oV9DHq-c8f_89e_j5m3x6wa4SmW0ff9J3zbTwGiz1ogo8xYH1vMiV6GP47N_Qw_Hoc_pT26rBB90l3087_Asop_go</recordid><startdate>20180104</startdate><enddate>20180104</enddate><creator>Boisclair, David</creator><creator>Décarie, Yann</creator><creator>Laliberté-Auger, François</creator><creator>Michaud, Pierre-Carl</creator><creator>Vincent, Carole</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0003-3114-4229</orcidid></search><sort><creationdate>20180104</creationdate><title>The economic benefits of reducing cardiovascular disease mortality in Quebec, Canada</title><author>Boisclair, David ; Décarie, Yann ; Laliberté-Auger, François ; Michaud, Pierre-Carl ; Vincent, Carole</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-87798a38d68e53dc19c63cdd2f7bf38202e5281696cdf5f43801268048a213c83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>21st century</topic><topic>Aging</topic><topic>Analysis</topic><topic>Biology and Life Sciences</topic><topic>Cardiovascular disease</topic><topic>Cardiovascular diseases</topic><topic>Computer simulation</topic><topic>Control</topic><topic>Demographics</topic><topic>Diabetes</topic><topic>Disease prevention</topic><topic>Economic aspects</topic><topic>Health care</topic><topic>Health care costs</topic><topic>Heart attacks</topic><topic>Hospitals</topic><topic>Life expectancy</topic><topic>Life span</topic><topic>Medicine and Health Sciences</topic><topic>Mortality</topic><topic>Patient outcomes</topic><topic>People and places</topic><topic>Population</topic><topic>Risk analysis</topic><topic>Risk factors</topic><topic>Social Sciences</topic><topic>Stroke</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Boisclair, David</creatorcontrib><creatorcontrib>Décarie, Yann</creatorcontrib><creatorcontrib>Laliberté-Auger, François</creatorcontrib><creatorcontrib>Michaud, Pierre-Carl</creatorcontrib><creatorcontrib>Vincent, Carole</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints database</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>ProQuest Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>Biological Sciences</collection><collection>Agriculture Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest advanced technologies &amp; aerospace journals</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Boisclair, David</au><au>Décarie, Yann</au><au>Laliberté-Auger, François</au><au>Michaud, Pierre-Carl</au><au>Vincent, Carole</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The economic benefits of reducing cardiovascular disease mortality in Quebec, Canada</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2018-01-04</date><risdate>2018</risdate><volume>13</volume><issue>1</issue><spage>e0190538</spage><epage>e0190538</epage><pages>e0190538-e0190538</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>We assess how different scenarios of cardiovascular disease (CVD) prevention, aimed at meeting targets set by the World Health Organization (WHO) for 2025), may impact healthcare spending in Quebec, Canada over the 2050 horizon. We provide long-term forecasts of healthcare use and costs at the Quebec population level using a novel dynamic microsimulation model. Using both survey and administrative data, we simulate the evolution of the Quebec population's health status until death, through a series of dynamic transitions that accounts for social and demographic characteristics associated with CVD risk factors. A 25% reduction in CVD mortality between 2012 and 2025 achieved through decreased incidence could contain the pace of healthcare cost growth towards 2050 by nearly 7 percentage points for consultations with a physician, and by almost 9 percentage points for hospitalizations. Over the 2012-2050 period, the present value of cost savings is projected to amount to C$13.1 billion in 2012 dollars. The years of life saved due to improved life expectancy could be worth another C$38.2 billion. Addressing CVD mortality directly instead would bring about higher healthcare costs, but would generate more value in terms of years of life saved, at C$69.6 billion. Potential savings associated with plausible reductions in CVD, aimed at reaching a World Health Organization target over a 12-year period, are sizeable and may help address challenges associated with an aging population.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>29300783</pmid><doi>10.1371/journal.pone.0190538</doi><tpages>e0190538</tpages><orcidid>https://orcid.org/0000-0003-3114-4229</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2018-01, Vol.13 (1), p.e0190538-e0190538
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_1985141652
source Open Access: PubMed Central; Publicly Available Content (ProQuest)
subjects 21st century
Aging
Analysis
Biology and Life Sciences
Cardiovascular disease
Cardiovascular diseases
Computer simulation
Control
Demographics
Diabetes
Disease prevention
Economic aspects
Health care
Health care costs
Heart attacks
Hospitals
Life expectancy
Life span
Medicine and Health Sciences
Mortality
Patient outcomes
People and places
Population
Risk analysis
Risk factors
Social Sciences
Stroke
title The economic benefits of reducing cardiovascular disease mortality in Quebec, Canada
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T02%3A33%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20economic%20benefits%20of%20reducing%20cardiovascular%20disease%20mortality%20in%20Quebec,%20Canada&rft.jtitle=PloS%20one&rft.au=Boisclair,%20David&rft.date=2018-01-04&rft.volume=13&rft.issue=1&rft.spage=e0190538&rft.epage=e0190538&rft.pages=e0190538-e0190538&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0190538&rft_dat=%3Cgale_plos_%3EA521670748%3C/gale_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c692t-87798a38d68e53dc19c63cdd2f7bf38202e5281696cdf5f43801268048a213c83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1985141652&rft_id=info:pmid/29300783&rft_galeid=A521670748&rfr_iscdi=true